Home > Boards > US Listed > Biotechs > Blueprint Medicines Corporation (BPMC)

BPMC 8-k filed, published proof of concept data:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
north40000 Member Profile
Member Level 
Followed By 219
Posts 17,388
Boards Moderated 0
Alias Born 01/19/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/20/2022 8:08:59 AM
Blueprint Medicines Elevates Two Talented Leaders to its Executive Team PR Newswire (US) - 1/20/2022 8:00:00 AM
JMP Securities Thinks Blueprint Medicines’ Stock is Going to Recover TipRanks - 1/12/2022 1:40:36 PM
Blueprint Medicines expects FY21 revenue at high end of $170M-$180M guidance range Seeking Alpha - 1/10/2022 2:16:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/10/2022 8:28:30 AM
Blueprint Medicines Provides 2022 Portfolio Goals Targeting Expanded Precision Therapy Leadership PR Newswire (US) - 1/10/2022 8:00:00 AM
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 1/6/2022 4:01:00 PM
JMP Securities Keeps Their Buy Rating on Blueprint Medicines (BPMC) TipRanks - 1/6/2022 12:15:42 AM
Blueprint Medicines names new CEO in leadership shakeup Seeking Alpha - 1/5/2022 8:40:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2022 8:08:51 AM
Blueprint Medicines Announces CEO and Leadership Transition Plan PR Newswire (US) - 1/5/2022 8:00:00 AM
Blueprint Medicines completes acquisition of Lengo Therapeutics Seeking Alpha - 12/30/2021 9:16:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/30/2021 9:12:03 AM
Blueprint Medicines Completes Acquisition of Lengo Therapeutics PR Newswire (US) - 12/30/2021 8:51:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/23/2021 5:10:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/17/2021 4:03:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2021 4:24:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/10/2021 4:26:35 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/10/2021 4:25:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/9/2021 4:03:19 PM
Blueprint Medicines Appoints Daniella Beckman to its Board of Directors PR Newswire (US) - 12/9/2021 4:01:00 PM
Blueprint Medicines grants non-qualified stock options to 13 new employees Seeking Alpha - 12/7/2021 4:08:25 PM
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 12/7/2021 4:01:00 PM
Nature Medicine Publishes Results from Two Registration Studies of AYVAKIT® (avapritinib) Showing Sustained Benefits in Patients with Advanced Systemic Mastocytosis PR Newswire (US) - 12/6/2021 4:01:00 PM
Blueprint Medicines to acquire precision oncology company Lengo Therapeutics Seeking Alpha - 11/29/2021 8:00:26 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences